FibroBiologics Inc Sustainability Reports
FibroBiologics, Inc. is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
LEI: 5493000KQEGHXVWRMZ92
1 reports from 2024 to 2024
